Article
Pharmacokinetics and absolute bioavailability of lansoprazole.
European journal of clinical pharmacology - 1 Jan 1996
Gerloff J, Mignot A, Barth H, Heintze K
Abstract excerpt
OBJECTIVE: In a crossover study 12 healthy volunteers received lansoprazole 15 mg or 30 mg orally, or 15 mg intravenously in randomized order as a single dose. Blood samples were taken and plasma levels of lansoprazole were determined using an HPLC method. The volunteers were phenotyped for the d...
Topics
- 2-Pyridinylmethylsulfinylbenzimidazoles
- Administration, Oral
- Adult
- Analysis of Variance
- Anti-Ulcer Agents
- Biological Availability
- Cross-Over Studies
- Humans
- Injections, Intravenous
- Lansoprazole
- Male
- Middle Aged
